Exosomes from CIITA-transfected CT26 cells enhance anti-tumor effects

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 987-991

  Fan, Wen ^a   Tian, Xing De ^a   Huang, E ^a   Zhang, Jia Jun ^a  

^a YANGTZE UNIVERSITY   (China)

Author keywords

Cancer vaccine; CIITA transfection; Exosomes; IFN production

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; CD86 ANTIGEN; GAMMA INTERFERON; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLON TUMOR; CYTOLOGY; DENDRITIC CELL; DISEASE MODEL; EXOSOME; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; SECRETION (PROCESS); SPLEEN; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EXOSOMES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; NUCLEAR PROTEINS; RNA, MESSENGER; SPLEEN; TRANS-ACTIVATORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877682356     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.987     Document Type: Article

References (28)

1. André F, Chaput N, Schartz NE, et al, (2004). Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol, 172, 2126-36.
2. Bobrie A, Colombo M, Raposo G, et al, (2011). Exosome secretion: molecular mechanisms and roles in immune responses. Traffic, 12, 1659-68.
3. Caby MP, Lankar D, Vincendeau-Scherrer C, et al, (2005). Exosomal-like vesicles are present in human blood plasma. Int Immunol, 17, 879-87.
4. Chaput N, Théry C (2011). Exosomes: immune properties and potential clinical implementations. Semin Immunopathol, 33, 419-40.
5. Cheng Y, Sanderson C, Jones M, et al, (2012). Low MHC class II diversity in the Tasmanian devil (Sarcophilus harrisii). Immunogenetics, 64, 525-33.
6. Cho JA, Lee YS, Kim SH, et al, (2009). MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generatetumor regression in murine models. Cancer Lett, 275, 256-65.
7. de Vrij J, Maas SL, Hegmans JP, et al, (2011).[Exosomes and cancer]. Ned Tijdschr Geneeskd, 155, A3677.
8. Filipazzi P, Bürdek M, Villa A, et al, (2012). Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol, 22, 342-9.
9. Frangione V, Mortara L, Castellani P, et al, (2010).CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy. Int J Cancer, 127, 1614-24.
10. Gastpar R, Gehrmann M, Bausero MA, et al, (2005). Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res, 65, 5238-47.
11. Hao S, Yuan J, Xiang J (2007). Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory. J Leukoc Biol, 82, 829-38.
12. Luketic L, Delanghe J, Sobol PT, et al, (2007). Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol, 179, 5024-32.
13. Lv LH, Wan YL, Lin Y, et al, (2012).Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell anti-tumor responses in vitro. J Biol Chem, 287, 15874-85.
14. Martin-Jaular L, Nakayasu ES, Ferrer M, et al, (2011). Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. PLoS One, 6, e26588.
15. Mathias RA, Lim JW, Ji H, et al, (2009). Isolation of extracellular membranous vesicles for proteomic analysis. Methods Mol Biol, 528, 227-42.
16. Morse MA, Secord AA, Blackwell K, et al, (2011). MHC class I-presented tumor antigens identified in ovarian cancer by immunoprot-eomic analysisare targets for T-cell responses against breast and ovarian cancer. Clin Cancer Res, 17, 3408-19.
17. Mortara L, Castellani P, Meazza R, et al, (2006). CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Clin Cancer Res, 12, 3435-43.
18. Nazarenko I, Rana S, Baumann A, et al, (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res, 70, 1668-78.
19. Rountree RB, Mandl SJ, Nachtwey JM, et al, (2011). Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res, 71, 5235-44.
20. Sartoris S, Brendolan A, Degola A, et al, (2000). Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum Immunol, 61, 599-604.
21. Schnitzer JK, Berzel S, Fajardo-Moser M, et al, (2010). Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine, 28, 5785-93.
22. Silva J, Garcia V, Rodriguez M, et al, (2012). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer, 51, 409-18.
23. Southcombe J, Tannetta D, Redman C, et al, (2011). The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One, 6, e20245.
24. Tan A, De La Peña H, Seifalian AM, (2010). The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine, 5, 889-900.
25. van Niel G, Raposo G, Candalh C, et al, (2001). Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology, 121, 337-49.
26. Verweij FJ, van Eijndhoven MA, Hopmans ES, et al, (2011). LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation. EMBO J, 30, 2115-29.
27. Viaud S, Théry C, Ploix S, et al, (2010). Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res, 70, 1281-5.
28. Wiley RD, Gummuluru S (2006). Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA, 103, 738-43.